'Sanofi's Consumer Arm Said to Draw Bids From Advent, PAI, CD&R' - Bloomberg
Portfolio Pulse from Benzinga Newsdesk
Sanofi's consumer health division has attracted first-round bids from private equity firms Advent International, PAI Partners, and Clayton Dubilier & Rice. The unit, which includes products like Phytoxil cough syrups and Icy Hot pain relief gels, is valued at up to €15 billion ($16 billion).
July 17, 2024 | 12:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sanofi's consumer health division has received first-round bids from private equity firms, potentially valuing the unit at up to €15 billion ($16 billion).
The bids for Sanofi's consumer health division indicate strong interest and a high valuation, which could positively impact Sanofi's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100